Abstract
The concept of negative symptoms tries to operationalize a deficit syndrome observed in schizophrenia, but also in other disorders. The instruments for the measurement developed so far are unclear in their dimensional structure and validity. Further methodological development is needed. A new scale for measuring negative symptoms was derived from the AMDP-system and applied to results of drug trials with clozapine, fluperlapine, and haloperidol. The three drugs were equally effective on negative symptoms of acute and chronic schizophrenics.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Andreasen NC (1982) Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 39:784–788
Andreasen NC, Olsen S (1982) Negative versus positive schizophrenia: definition and validation. Arch Gen Psychiatry 39:789–794
Angst J, Dinkelkamp T (1974) Die somatische Therapie der Schizophrenie. Literature der Jahre 1966–1972 (Sammlung psychiatrischer und neurologischer Einzeldarstellungen). Thieme, Sluttgart
Angst J, Woggon B (1983) Validity of the AMP-system for its use in clinical psychopharmacology. In: Bobon D, Baumann U, Angst J, Helmchen H, Hippius H (eds) The AMDP-system in pharmacopsychiatry (Modern problems of pharmacopsychiatry, vol 20). Karger, Basel, pp 174–184
Ban TA, Guy W, Wilson WH (1985) The AMDP-system in chronic hospitalized schizophrenics. Compr Psychiatry 26:370–374
Barnes TR, Braude WM (1985) Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 42:874–878
Bleuler E (1911) Dementia praecox oder Gruppe der Schizophrenien. In: Aschaffenburg G (Hrsg) Handbuch der Psychiatrie, spez. Teil 4/I. Deuticke, Leipzig Wien, S 1–420
Bleuler M (1972) Die schizophrenen Geistesstörungen im Lichte langjähriger Kranken- und Familiengeschichten. Thieme, Stuttgart
Carpenter WT, Jr, Heinrichs DW, Alphs LD (1985) Treatment of negative symptoms. Schizophr Bull 11:440–452
Ciompi L, Lai GP (1969) Dépression et vieillesse. Etudes catamnestiques sur le vieillissement et la mortalité de 555 ancien patients dépressifs. Huber, Bern
Ciompi L, Müller C (1976) Lebensweg und Alter der Schizophrenen. Eine katamnestische Langzeitstudie bis ins Senium. Springer, Berlin Heidelberg New York
Conrad K (1958) Die Beginnende Schizophrenie. Versuch einer Gestaltanalyse des Wahns. Thieme, Stuttgart
Crow TJ (1985) The two-syndrome concept: origins and current status. Schizophr Bull 11:471–486
Csesernansky JG, Kaplan J, Holman CA, Hollister LE (1983) Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients. Psychopharmacology 81:115–118
Ernst K (1962) Neurotische und endogene Residualzustände. Arch Psychiatr Neurol 203:61–84
Gibbons RD, Lewine RRJ, Davis JM, Schooler NR, Cole JO (1985) An empirical test of a Kraepelinian versus a Bleulerian view of negative symptoms. Schizophr Bull 11:390–396
Glatzel J (1967) Zur Frage der schizophrenen Verläufe unter der Pharmakotherapie. Arch Psychiatr Nervenkr 209:87–100
Goffman E (1961) Asylums. Anchor Books, New York
Goldberg SC (1985) Negative and deficit symptoms in schizophrenia do respond to neuroleptics. Schizophr Bull 11:453–456
Good I (1988) Sogenannte Minussymptome bei chronischer Schizophrenie. Interrater-Reliabilitäts-Untersuchung an zwei Negativsymptom-Skalen (SANS, NSRS). Med. Dissertation, Zürich (in Vorberitung)
Grau BW, Mueser KT (1986) Measurement of negative symptoms. Schizophr Bull 12:7–8
Heinrich K (1967) Zur Bedeutung des postremissiven Erschöpfungs-Syndroms für die Rehabilitation Schizophrener. Nervenarzt 38:487–491
Hirsch SR, Knights A (1982) Gibt es die pharmakogene Depression wirklich? Beweismaterial aus zwei prospektiven Untersuchungen. In: Kryspin-Exner K, Hinterhuber H, Schubert H (Hrsg) Ergebnisse der psychiatrischen Therapieforschung. Schattauer, Stuttgart New York, S 249–268
Hoffman WF, Labs SM, Casey DE (1987) Neuroleptic-induced Parkinsonism in older schizophrenics. Biol Psychiatry 22:427–439
Huber G (1957) Pneumencephalographische und psychopathologische Bilder bei endogenen Psychosen. Springer, Berlin Göttingen Heidelberg
Huber G, Gross G, Schüttler R (1979) Schizophrenie. Verlaufs-und sozialpsychiatrische Langzeituntersuchungen an den 1945–1959 in Bonn hospitalisierten schizophrenen Kranken. Springer, Berlin Heidelberg New York
Iager AC, Kirch DG, Wyatt RJ (1985) A negative symptom rating scale. Psychiatry Res 16:27–36
Jackson JH (1884) Evolution and dissolution of the nervous system. In: Taylor J (ed) Selected writings of John Hughlings Jackson, vol 2: various papers, addresses and lectures. Basic Books, New York (1958)
Janzarik W (1959) Dynamische Grundkonstellationen in endogenen Psychosen. Ein Beitrag zur Differentialtypologie der Wahnphänomene (Monographien aus dem Gesamtgebiete der Neurologie und Psychiatric, Heft 86). Springer, Berlin Göttingen Heidelberg
Kay SR, Opler LA (1987) The positive-negative dimension in schizophrenia: its validity and significance. Psychiatr Dev 5:79–103
Koehler K, Sauer H (1984) Huber's basic symptoms: another approach to negative psychopathology in schizophrenia. Compr Psychiatry 25:174–182
Lewine RRJ, Fogg L, Meltzer HY (1983) Assessment of negative and positive symptoms in schizophrenia. Schizophr Bull 9:368–376
Mayer-Gross W (1920) Ueber die Stellungnahme zur abgelaufenen akuten Psychose. Eine Studie über verständliche Zusammenhänge in der Schizophrenie. Z Gesamte Neurol Psychiatr 60:160–212
Meltzer HY, Sommers AA, Luchins DJ (1986) The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia. J Clin Pharmacol 6:329–338
Möller HJ, Zerssen D von (1981) Depressive Symptomatik bei Aufnahme und Entlassung stationär behandelter schizophrener Patienten. Nervenarzt 52:525–530
Möller HJ, Zerssen D von (1986) Der Verlauf schizophrener Psychosen unter den gegenwärtigen Behandlungsbedingungen. Springer, Berlin Heidelberg New York Tokyo
Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799–812
Prosser ES, Csernansky JG, Kaplan J, Thiemann S, Becker TJ, Hollister LE (1987) Depression, Parkinsoniabn symptoms, and negative symptoms in schizophrenics treated with neuroleptics. J Nerv Ment Dis 175:100–105
Sommers AA (1985) “Negative symptoms”: conceptual and methodological problems. Schizophr Bull 11:364–379
Straumann D (1988) Sogenannte Minussymptome bei chronischer Schizophrenie. Eine psychopathologische Untersuchung an 50 stationären Patienten. Med. Dissertation, Zürich (in Vorbereitung)
Strauss J, Carpenter WT Jr, Bartko J (1974) The diagnosis and understanding of schizophrenia: Part III. Speculation on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 1/11:61–69
Waddington JL, Youssef HA (1986) Late onset involuntary mouvements in chronic schizophrenia: relationship of ‘tardive’ dyskinesia to intellectual impairment and negative symptoms. Br J Psychiatry 149:616–620
Waddington JL, Youssef HA, Molloy AG, O'Boyle KM, Pugh MT (1985) Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies. J Clin Psychiatry 46:29–33
Waddington JL, Youssef HA, Dolphin C, Kinsella A (1987) Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality. Arch Gen Psychiatry 44:907–912
Woggon B, Angst J (1976) Einzelne Aspekte der Behandlung mit depotneuroleptika. In: Huber G (Hrsg). Therapie, Rehabilitation und Prävention schizophrener Erkrankungen. 3. “Weissenauer” Schizophreniesymposion, Lübeck-Travemünde 1975. Schattauer, Stuttgart New York, S 191–200
Woggon B, Beckmann H, Heinrich K, Linden M, Krebs E, Küfferle B, Pflug B, Rüther E, Schied HW (1986) Clinically relevant differences in the therapeutic profile of fluperlapine compared to Haloperidol in the treatment of schizophrenic psychosis. Results of a multicentre double-blind study. Pharmacopsychiatria 19:204–205
Zubin J (1985)Negative symptoms: are they indigenous to schizophrenia? Schizophr Bull 11:461–470
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Angst, J., Stassen, H.H. & Woggon, B. Effect of neuroleptics on positive and negative symptoms and the deficit state. Psychopharmacology 99 (Suppl 1), S41–S46 (1989). https://doi.org/10.1007/BF00442558
Issue Date:
DOI: https://doi.org/10.1007/BF00442558